{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:54:54Z","timestamp":1785596094609,"version":"3.56.0"},"publisher-location":"Berlin, Heidelberg","reference-count":230,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/164_2024_720","type":"book-chapter","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:01:50Z","timestamp":1717700510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Roles of \u03b2-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders"],"prefix":"10.1007","author":[{"given":"Yee Weng","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Haqqani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"720_CR1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.0000139844.15045.F9","volume":"110","author":"I Ahmet","year":"2004","unstructured":"Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG, Talan MI (2004) Beneficial effects of chronic pharmacological manipulation of \u03b2-adrenoceptor subtype signalling in rodent dilated ischemic cardiomyopathy. Circulation 110:1083\u20131090","journal-title":"Circulation"},{"key":"720_CR2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS, Board of Directors of the American Headache Society (2021) The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice. Headache 61:1021\u20131039","journal-title":"Headache"},{"key":"720_CR3","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","volume":"283","author":"ALLHAT Collaborative Research Group","year":"2000","unstructured":"ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283:1967\u20131975","journal-title":"JAMA"},{"key":"720_CR4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","volume":"376","author":"JL Anderson","year":"2017","unstructured":"Anderson JL, Morrow DA (2017) Acute Myocardial Infarction. N Engl J Med 376:2053\u20132064","journal-title":"N Engl J Med"},{"key":"720_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","volume":"64","author":"C Andersson","year":"2014","unstructured":"Andersson C, Shilane D, Go AS, Chang TI, Kazi D, Solomon MD, Boothroyd DB, Hlatky MA (2014) \u03b2-Blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol 64:247\u2013252","journal-title":"J Am Coll Cardiol"},{"key":"720_CR6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1440-1681.2000.03369.x","volume":"27","author":"JA Angus","year":"2000","unstructured":"Angus JA, Sarsero D, Fujiwara T, Molenaar P, Xi Q (2000) Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues. Clin Exp Pharmacol Physiol 27:1019\u20131021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"720_CR7","doi-asserted-by":"crossref","unstructured":"Aumann KW, Youmans WB (1940) Differential sensitization of adrenergic neuro-effector systems by thyroid hormone. J Physiol 131:394-4011","DOI":"10.1152\/ajplegacy.1940.131.2.394"},{"key":"720_CR8","doi-asserted-by":"crossref","first-page":"15863","DOI":"10.1016\/S0021-9258(18)98488-7","volume":"266","author":"SW Bahouth","year":"1991","unstructured":"Bahouth SW (1991) Thyroid hormones transcriptionally regulate the \u03b21-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem 266:15863\u201315869","journal-title":"J Biol Chem"},{"key":"720_CR9","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1006\/jmcc.1997.0549","volume":"29","author":"SW Bahouth","year":"1997","unstructured":"Bahouth SW, Cui X, Beauchamp MJ, Park EA (1997) Thyroid hormone induces \u03b21-adrenergic receptor gene transcription through a direct repeat separated by five nucleotides. J Mol Cell Cardiol 29:3223\u20133237","journal-title":"J Mol Cell Cardiol"},{"key":"720_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","volume":"14","author":"JG Baker","year":"2005","unstructured":"Baker JG (2005) The selectivity of \u03b2-adrenoceptor antagonists at human \u03b21, \u03b22 and \u03b23 adrenoceptors. Br J Pharmacol 14:317\u2013322","journal-title":"Br J Pharmacol"},{"key":"720_CR11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","volume":"127","author":"S Bangalore","year":"2014","unstructured":"Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD, DiNicolantonio JJ, Devereaux PJ, Alexander KP, Wetterslev J, Messerli FH (2014) Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 127:939\u2013953","journal-title":"Am J Med"},{"key":"720_CR12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.yjmcc.2009.11.014","volume":"48","author":"D Barefield","year":"2010","unstructured":"Barefield D, Sadayappan S (2010) Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol 48:866\u2013875","journal-title":"J Mol Cell Cardiol"},{"key":"720_CR13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3748\/wjg.v18.i11.1166","volume":"18","author":"K Bari","year":"2012","unstructured":"Bari K, Garcia-Tsao G (2012) Treatment of portal hypertension. World J Gastroenterol 18:1166\u20131175","journal-title":"World J Gastroenterol"},{"key":"720_CR14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1476-5381.1970.tb10619.x","volume":"40","author":"AM Barrett","year":"1970","unstructured":"Barrett AM, Carter J (1970) Comparative chronotropic activity of \u03b2-adrenoceptive antagonists. Br J Pharmacol 40:373\u2013381","journal-title":"Br J Pharmacol"},{"key":"720_CR15","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1038\/s41467-022-34765-w","volume":"13","author":"T Benkel","year":"2022","unstructured":"Benkel T, Zimmermann M, Zeiner J, Bravo S, Merten N, Lim V, Matthees E, Drube J, Miess-Tanneberg E, Malan D, Szpakowska M, Monteleone S, Grimes J, Koszegi Z, Lanoisel\u00e9e Y, O\u2019Brien S, Pavlaki N, Dobberstein N, Inoue A, Nikolaev V, Calebiro D, Chevign\u00e9 A, Sasse P, Schulz S, Hoffmann C, Kolb P, Waldhoer M, Simon K, Gomeza J, Kostenis E (2022) How carvedilol activates \u03b22-adrenoceptors. Nat Commun 13:7109","journal-title":"Nat Commun"},{"key":"720_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.2552582","volume":"246","author":"JL Benovic","year":"1989","unstructured":"Benovic JL, DeBlasi A, Stone WC, Caron MG, Lefkowitz RJ (1989) Beta-adrenergic receptor kinase: primary structure delineates a multigene family. Science 246:235\u2013240","journal-title":"Science"},{"key":"720_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCRESAHA.120.318234","volume":"129","author":"F Berisha","year":"2021","unstructured":"Berisha F, G\u00f6tz KR, Wegener JW, Brandenburg S, Subramanian H, Molina CE, R\u00fcffer A, Petersen J, Bernhardt A, Girdauskas E, Jungen C, Pape U, Kraft AE, Warnke S, Lindner D, Westermann D, Blankenberg S, Meyer C, Hasenfu\u00df G, Lehnart SE, Nikolaev VO (2021) cAMP imaging at ryanodine receptors reveals \u03b22-adrenoceptor driven arrhythmias. Circ Res 129:81\u201394","journal-title":"Circ Res"},{"key":"720_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415:198\u2013205","journal-title":"Nature"},{"key":"720_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0008-6363(99)00038-3","volume":"42","author":"DM Bers","year":"1999","unstructured":"Bers DM, Perez-Reyes E (1999) Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc Res 42:339\u2013360","journal-title":"Cardiovasc Res"},{"key":"720_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/oxfordjournals.bmb.a070988","volume":"29","author":"JW Black","year":"1973","unstructured":"Black JW, Prichard BNC (1973) Activation and blockade of \u03b2 adrenoceptors in common cardiac disorders. Br Med Bull 29:163\u2013167","journal-title":"Br Med Bull"},{"key":"720_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(62)90103-4","volume":"2","author":"JW Black","year":"1962","unstructured":"Black JW, Stephenson JS (1962) Pharmacology of a new adrenergic beta-receptor-blocking compound (nethalide). Lancet 2:311\u2013314","journal-title":"Lancet"},{"key":"720_CR22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1476-5381.1965.tb01782.x","volume":"25","author":"JW Black","year":"1965","unstructured":"Black JW, Duncan WA, Shanks RG (1965) Comparison of some properties of pronethalol and propranolol. Br J Pharmacol Chemother 25:577\u2013591","journal-title":"Br J Pharmacol Chemother"},{"key":"720_CR23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1749-6632.1967.tb41237.x","volume":"139","author":"JR Blinks","year":"1967","unstructured":"Blinks JR (1967) Evaluation of the cardiac effects of several beta adrenergic blocking agents. Ann N Y Acad Sci 139:673\u2013685","journal-title":"Ann N Y Acad Sci"},{"key":"720_CR24","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI27167","volume":"115","author":"I Bodi","year":"2005","unstructured":"Bodi I, Mikala G, Koch SE, Akhter SA, Schwartz A (2005) The L-type calcium channel in the heart: the beat goes on. J Clin Invest 115:3306\u20133317","journal-title":"J Clin Invest"},{"key":"720_CR25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1988.tb11698.x","volume":"95","author":"RA Bond","year":"1988","unstructured":"Bond RA, Clarke DE (1988) Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the \u03b1- and \u03b2 -subtypes. Br J Pharmacol 95:723\u2013734","journal-title":"Br J Pharmacol"},{"key":"720_CR26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/374272a0","volume":"374","author":"RA Bond","year":"1995","unstructured":"Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, McMinn TR, Apparsundaram S, Hyek MF, Kenakin TP, Allen LF, Lefkowitz RJ (1995) Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the \u03b22-adrenoceptor. Nature 374:272\u2013276","journal-title":"Nature"},{"key":"720_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats A, Tsutsui H (2021) Universal definition and classification of heart failure. J Card Fail 27:387\u2013413","journal-title":"J Card Fail"},{"key":"720_CR28","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.113.001258","volume":"127","author":"E Braunwald","year":"2013","unstructured":"Braunwald E, Morrow DA (2013) Unstable angina: is it time for a requiem? Circulation 127:2452\u20132457","journal-title":"Circulation"},{"issue":"101","key":"720_CR29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","volume":"2000","author":"MR Bristow","year":"2000","unstructured":"Bristow MR (2000) \u03b2-Adrenergic receptor blockade in chronic heart failure. Circulation 2000(101):558\u2013569","journal-title":"Circulation"},{"key":"720_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","volume":"307","author":"MR Bristow","year":"1982","unstructured":"Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and \u03b2-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205\u2013211","journal-title":"N Engl J Med"},{"key":"720_CR31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","volume":"59","author":"MR Bristow","year":"1986","unstructured":"Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S (1986) Beta1- and beta2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 59:297\u2013309","journal-title":"Circ Res"},{"issue":"Supplement 1","key":"720_CR32","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/00005344-199219001-00014","volume":"19","author":"MR Bristow","year":"1992","unstructured":"Bristow MR, Larrabee P, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port J, M\u00fcller-Beckmann B (1992) Receptor pharmacology of carvedilol in the human heart. J Cardiovasc Pharmacol 19(Supplement 1):S68\u2013S80","journal-title":"J Cardiovasc Pharmacol"},{"key":"720_CR33","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","volume":"94","author":"MR Bristow","year":"1996","unstructured":"Bristow MR, Gilbert EM, Abraham WT, Adams KR, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusteman N, for the MOCHA Investigators (1996) Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94:2807\u20132816","journal-title":"Circulation"},{"key":"720_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cardfail.2003.10.009","volume":"9","author":"MR Bristow","year":"2003","unstructured":"Bristow MR, Feldman AM, Adams KF, Goldstein S (2003) Selective versus nonselective \u03b2-blockade for heart failure therapy: are there lessons to be learned from the COMET trial? J Cardiac Fail 9:444\u2013453","journal-title":"J Cardiac Fail"},{"key":"720_CR35","first-page":"203","volume":"43","author":"O-E Brodde","year":"1991","unstructured":"Brodde O-E (1991) \u03b21- and \u03b22-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203\u2013242","journal-title":"Pharmacol Rev"},{"key":"720_CR36","first-page":"651","volume":"51","author":"O-E Brodde","year":"1999","unstructured":"Brodde O-E, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651\u2013689","journal-title":"Pharmacol Rev"},{"key":"720_CR37","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1161\/CIRCULATIONAHA.110.964619","volume":"122","author":"H Bundgaard","year":"2010","unstructured":"Bundgaard H, Liu C-C, Garcia A, Hamilton EJ, Huang Y, Chia KKM, Hunyor SN, Figtree GA, Rasmussen HH (2010) Adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification. Circulation 122:2699\u20132708","journal-title":"Circulation"},{"key":"720_CR38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ejhf.714","volume":"19","author":"H Bundgaard","year":"2017","unstructured":"Bundgaard H, Axelsson A, Thomsen JH, S\u00f8rgaard M, Kofoed KF, Hasselbalch R, Fry NAS, Valeur N, Boesgaard S, Gustafsoon F, K\u00f8ber L, Iversen K, Rasmussen HH (2017) The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial. Eur J Heart Fail 19:566\u2013575","journal-title":"Eur J Heart Fail"},{"key":"720_CR39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","volume":"301","author":"L Butters","year":"1990","unstructured":"Butters L, Kennedy S, Rubin PC (1990) Atenolol in essential hypertension during pregnancy. BMJ 301:587\u2013589","journal-title":"BMJ"},{"key":"720_CR40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1476-5381.1987.tb11324.x","volume":"92","author":"BF Buxton","year":"1987","unstructured":"Buxton BF, Jones CR, Molenaar P, Summers RJ (1987) Characterization and autoradiographic localization of \u03b2-adrenoceptor subtypes in human cardiac tissues. Br J Pharmacol 92:299\u2013310","journal-title":"Br J Pharmacol"},{"key":"720_CR41","first-page":"649","volume":"290","author":"MR Candelore","year":"1999","unstructured":"Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, Weber AE (1999) Potent and selective human \u03b23-adrenergic receptor antagonists. J Pharmacol Exp Ther 290:649\u2013655","journal-title":"J Pharmacol Exp Ther"},{"key":"720_CR42","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.bpj.2013.03.058","volume":"104","author":"MB Cannell","year":"2013","unstructured":"Cannell MB, Kong CHT, Imtiaz MS, Laver DR (2013) Control of sarcoplasmic reticulum Ca2+ release by stochastic RyR gating within a 3D model of the cardiac dyad and importance of induction decay for CICR termination. Biophys J 104:2149\u20132159","journal-title":"Biophys J"},{"key":"720_CR43","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","volume":"357","author":"CAPRICORN investigators","year":"2001","unstructured":"CAPRICORN investigators (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357:1385\u20131390","journal-title":"Lancet"},{"key":"720_CR44","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.108.804369","volume":"119","author":"NJ Chandler","year":"2009","unstructured":"Chandler NJ, Greener ID, Tellez JO, Shin Inada S, Musa H, Molenaar P, di Francesco D, Baruscotti M, Longhi R, Anderson RH, Billeter R, Vinod Sharma V, Sigg DC, Boyett MR, Dobrzynski H (2009) Molecular architecture of the human sinus node. Insights into the function of the cardiac pacemaker. Circulation 119:1562\u20131575","journal-title":"Circulation"},{"key":"720_CR45","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ar.21379","volume":"294","author":"N Chandler","year":"2011","unstructured":"Chandler N, Aslanidi O, Buckley D, Inada S, Birchall S, Atkinson A, Kirk D, Monfredi O, Molenaar P, Anderson R, Sharma V, Sigg D, Zhang H, Boyett M, Dobrzynski H (2011) Computer three-dimensional anatomical reconstruction of the human sinus node and a novel paranodal area. Anat Rec 294:970\u2013979","journal-title":"Anat Rec"},{"key":"720_CR46","doi-asserted-by":"crossref","unstructured":"Chatzidou S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, Kosmopoulos M, Papadopoulou E, Vasilopoulos G, Rokas S (2018) Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator. J Am Coll Cardiol 71:1897\u20131906","DOI":"10.1016\/j.jacc.2018.02.056"},{"key":"720_CR47","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/FPC.0b013e3282ef7354","volume":"17","author":"L Chen","year":"2007","unstructured":"Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler ABT, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P (2007) Arg389Gly-\u03b21-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol. Pharmacogenet Genomics 17:941\u2013949","journal-title":"Pharmacogenet Genomics"},{"key":"720_CR48","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/01.RES.87.12.1172","volume":"87","author":"A Chesley","year":"2000","unstructured":"Chesley A, Lundberg MS, Asai T, Xiao R-P, Ohtani S, Lakatta EG, Crow MT (2000) The \u03b22-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3\u2032-kinase. Circ Res 87:1172\u20131179","journal-title":"Circ Res"},{"key":"720_CR49","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.hlc.2016.06.789","volume":"25","author":"DP Chew","year":"2016","unstructured":"Chew DP, Scott IA, Cullen L, French JK, Briffa TG, Tideman PA, Woodruffe S, Kerr A, Branagan M, Aylward PE (2016) NHFA\/CSANZ ACS Guideline 2016 Executive Working Group: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart Lung Circ 25:895\u2013951","journal-title":"Heart Lung Circ"},{"key":"720_CR50","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","volume":"60","author":"P Chockalingam","year":"2012","unstructured":"Chockalingam P, Crotti L, Girardengo G, Johnson JN, Harris KM, van der Heijden JF, Hauer RN, Beckmann BM, Spazzolini C, Rordorf R, Rydberg A, Clur SA, Fischer M, van den Heuvel F, K\u00e4\u00e4b S, Blom NA, Ackerman MJ, Schwartz PJ, Wilde AA (2012) Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol 60:2092\u20132099","journal-title":"J Am Coll Cardiol"},{"key":"720_CR51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1476-5381.2010.00996.x","volume":"162","author":"T Christ","year":"2011","unstructured":"Christ T, Molenaar P, Klenowski PM, Ravens U, Kaumann AJ (2011) Human atrial \u03b21L-adrenoceptor but not \u03b23-adrenoceptor activation increases force and Ca2+ current at physiological temperature. Br J Pharmacol 162:823\u2013839","journal-title":"Br J Pharmacol"},{"key":"720_CR52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","unstructured":"CIBIS-II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study II (CIBIS-II) a randomised trial. Lancet 353:9\u201313","journal-title":"Lancet"},{"key":"720_CR53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819\u2013823","journal-title":"N Engl J Med"},{"key":"720_CR54","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","volume":"314","author":"JN Cohn","year":"1986","unstructured":"Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shar PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a veterans administration cooperative study. N Engl J Med 314:1547\u20131552","journal-title":"N Engl J Med"},{"key":"720_CR55","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.94.11.2800","volume":"94","author":"WS Colucci","year":"1996","unstructured":"Colucci WS, Packer M, Bristow MR, Gilvert M, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA, for the US Carvedilol Heart Failure Study Group (1996) Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 94:2800\u20132806","journal-title":"Circulation"},{"key":"720_CR56","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1161\/01.CIR.100.22.2210","volume":"100","author":"C Communal","year":"1999","unstructured":"Communal C, Singh K, Sawyer DB, Colucci WS (1999) Opposing effects of \u03b21- and \u03b22-adrenergic receptors on cardiac myocyte apoptosis. Role of a pertussis toxin-sensitive G protein. Circulation 100:2210\u20132212","journal-title":"Circulation"},{"key":"720_CR57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0026-0495(76)90126-8","volume":"25","author":"P Coulombe","year":"1976","unstructured":"Coulombe P, Dussault JH, Walker P (1976) Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism. Metabolism 25:973\u2013979","journal-title":"Metabolism"},{"key":"720_CR58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00210-019-01780-6","volume":"393","author":"M Dal Monte","year":"2020","unstructured":"Dal Monte M, Evans BA, Arioglu-Inan E, Michel MC (2020) Upregulation of \u03b23-adrenoceptors\u2014a general marker of and protective mechanism against hypoxia? Naunyn Schmiedeberg's Arch Pharmacol 393:141\u2013146","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11940-019-0556-3","volume":"21","author":"A Danesh","year":"2019","unstructured":"Danesh A, Gottschalk PCH (2019) Beta-blockers for migraine prevention: a review article. Curr Treat Options Neurol 21:20","journal-title":"Curr Treat Options Neurol"},{"key":"720_CR60","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00003","volume":"3","author":"A Dashwood","year":"2020","unstructured":"Dashwood A, Cheesman E, Beard N, Haqqani H, Wong YW, Molenaar P (2020) Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure. ACS Pharmacol Transl Sci 3:563\u2013582","journal-title":"ACS Pharmacol Transl Sci"},{"key":"720_CR61","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0168-8278(96)80127-9","volume":"25","author":"R de Franchis","year":"1996","unstructured":"de Franchis R (1996) Developing consensus in portal hypertension. J Hepatol 25:390\u2013394","journal-title":"J Hepatol"},{"key":"720_CR62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C (2022) Baveno VII faculty. Baveno VII - renewing consensus in portal hypertension. J Hepatol 76:959\u2013974","journal-title":"J Hepatol"},{"key":"720_CR63","doi-asserted-by":"crossref","unstructured":"Denniss AL, Dashwood AM, Molenaar P, Beard NA (2020) Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure? Biphys Rev 12:865\u2013878","DOI":"10.1007\/s12551-020-00736-y"},{"key":"720_CR64","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.107.169011","volume":"102","author":"J DeSantiago","year":"2008","unstructured":"DeSantiago J, Ai X, Islam M, Acuna G, Ziolo MT, Bers DM, Pogwizd SM (2008) Arrhythomogenic effects of \u03b22-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res 102:1389\u20131397","journal-title":"Circ Res"},{"key":"720_CR65","doi-asserted-by":"crossref","first-page":"e010720","DOI":"10.1161\/CIRCINTERVENTIONS.121.010720","volume":"14","author":"L Desta","year":"2021","unstructured":"Desta L, Raposeiras-Roubin S, Ibanez B (2021) The art of prescribing \u03b2-blockers after myocardial infarction. Circ Cardiovasc Interv 14:e010720","journal-title":"Circ Cardiovasc Interv"},{"key":"720_CR66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2337\/diabetes.50.2.455","volume":"50","author":"\u00dcD Dincer","year":"2001","unstructured":"Dincer \u00dcD, Bidasee KR, G\u00fcner S, Tay A, \u00d6zcelikay AT, Altan VM (2001) The effects of diabetes on expression of \u03b21-, \u03b22-, and \u03b23-adrenoceptors in rat hearts. Diabetes 50:455\u2013461","journal-title":"Diabetes"},{"key":"720_CR67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-642-17575-6_11","volume-title":"Heart rate and rhythm","author":"H Dobrzynski","year":"2011","unstructured":"Dobrzynski H, Monfredi O, Greener ID, Atkinson A, Inada S, Taube M-A, Yanni J, Fedorenko O, Molenaar P, Anderson RH, Efimov IR, Boyett MR (2011) Molecular basis of the electrical activity of the atrioventricular junction and Purkinje fibres. In: Heart rate and rhythm. Springer, Berlin, Heidelberg, pp 211\u2013230"},{"key":"720_CR68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","volume":"109","author":"RN Doughty","year":"2004","unstructured":"Doughty RN, Whalley GA, Walsh HA, Gamble GD, L\u00f3pez-Send\u00f3n J, Sharpe N, CAPRICORN Echo Substudy Investigators (2004) Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 109:201\u2013206","journal-title":"Circulation"},{"key":"720_CR69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/jmcc.1994.1040","volume":"26","author":"J Elnatan","year":"1994","unstructured":"Elnatan J, Molenaar P, Rosenfeldt FL, Summers RJ (1994) Autoradiographic localization and quantitation of beta1- and beta2-adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. J Mol Cell Cardiol 26:313\u2013323","journal-title":"J Mol Cell Cardiol"},{"key":"720_CR70","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.2570461","volume":"245","author":"LJ Emorine","year":"1989","unstructured":"Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD (1989) Molecular characterization of the human \u03b23-adrenergic receptor. Science 245:1118\u20131121","journal-title":"Science"},{"issue":"11A","key":"720_CR71","doi-asserted-by":"crossref","first-page":"7L","DOI":"10.1016\/S0002-9149(97)00844-8","volume":"80","author":"M Esler","year":"1997","unstructured":"Esler M, Kaye D, Lambert G, Esler D, Jennings G (1997) Adrenergic nervous system in heart failure. Am J Cardiol 80(11A):7L\u201314L","journal-title":"Am J Cardiol"},{"key":"720_CR72","doi-asserted-by":"crossref","unstructured":"Fabiato A (1983) Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Phys 245:C1\u2013C14","DOI":"10.1152\/ajpcell.1983.245.1.C1"},{"key":"720_CR73","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1113\/jphysiol.1975.sp011026","volume":"249","author":"A Fabiato","year":"1975","unstructured":"Fabiato A, Fabiato F (1975) Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells. J Physiol 249:469\u2013495","journal-title":"J Physiol"},{"key":"720_CR74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.40.2.119","volume":"40","author":"A Fabiato","year":"1977","unstructured":"Fabiato A, Fabiato F (1977) Calcium release from the sarcoplasmic reticulum. Circ Res 40:119\u2013129","journal-title":"Circ Res"},{"key":"720_CR75","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev.ph.41.030179.002353","volume":"41","author":"A Fabiato","year":"1979","unstructured":"Fabiato A, Fabiato F (1979) Calcium and cardiac excitation-contraction coupling. Annu Rev Physiol 41:473\u2013484","journal-title":"Annu Rev Physiol"},{"key":"720_CR76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/CIRCRESAHA.116.308413","volume":"120","author":"VL Feigin","year":"2017","unstructured":"Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120:439\u2013448","journal-title":"Circ Res"},{"key":"720_CR77","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIR.0b013e3182776f83","volume":"126","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV (2012) American College of Cardiology Foundation. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 126:3097\u20133137","journal-title":"Circulation"},{"key":"720_CR78","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1196\/annals.1410.013","volume":"1148","author":"V Fischer","year":"2008","unstructured":"Fischer V, Gabauer I, Tillinger A, Novakova M, Pechan I, Krizanova O, Kvet\u0148ansk\u00fd R, Myslivecekc J (2008) Heart adrenoceptor gene expression and binding sites in the human failing heart. Ann N Y Acad Sci 1148:400\u2013408","journal-title":"Ann N Y Acad Sci"},{"key":"720_CR79","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI24569","volume":"115","author":"RS-Y Foo","year":"2005","unstructured":"Foo RS-Y, Mani K, Kitsis RN (2005) Death begets failure in the heart. J Clin Invest 115:565\u2013571","journal-title":"J Clin Invest"},{"key":"720_CR80","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) \u03b2 blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318:1730\u20131737","journal-title":"BMJ"},{"key":"720_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(86)80250-9","volume":"7","author":"LM Friedman","year":"1986","unstructured":"Friedman LM, Byington RP, Capone RJ, Furberg CD, Goldstein S, Lichstein E (1986) Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. J Am Coll Cardiol 7:1\u20138","journal-title":"J Am Coll Cardiol"},{"key":"720_CR82","doi-asserted-by":"crossref","first-page":"e006753","DOI":"10.1161\/CIRCHEARTFAILURE.119.006753","volume":"13","author":"NAS Fry","year":"2020","unstructured":"Fry NAS, Liu CC, Garcia A, Hamilton EJ, Galougahi KK, Kim YJ, Whalley DW, Bundgaard H, Rasmussen HH (2020) Targeting cardiac myocyte Na+-K+ pump function with \u03b23 adrenergic agonist in rabbit model of severe congestive heart failure. Circ Heart Fail 13:e006753","journal-title":"Circ Heart Fail"},{"key":"720_CR83","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI118823","volume":"98","author":"C Gauthier","year":"1996","unstructured":"Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H (1996) Functional \u03b23-adrenoceptor in the human heart. J Clin Invest 98:556\u2013562","journal-title":"J Clin Invest"},{"key":"720_CR84","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI2191","volume":"102","author":"C Gauthier","year":"1998","unstructured":"Gauthier C, Leblais V, Kobzik L, Trochu J-N, Khandoudi N, Bril A, Balligand J-L, Le Marec H (1998) The negative inotropic effect of \u03b23-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102:1377\u20131384","journal-title":"J Clin Invest"},{"key":"720_CR85","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00004872-200409000-00019","volume":"22","author":"G Grassi","year":"2004","unstructured":"Grassi G, Seravalle G, Dell\u2019Oro R, Facchini A, Ilardo V, Mancia G (2004) Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias. J Hypertens 22:1747\u20131753","journal-title":"J Hypertens"},{"key":"720_CR86","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.yjmcc.2010.12.017","volume":"50","author":"ID Greener","year":"2011","unstructured":"Greener ID, Monfredi O, Inada S, Chandler NJ, Tellez JO, Atkinson A, Taube M-A, Billeter R, Anderson RH, Efimov IR, Molenaar P, Sigg DC, Sharma V, Boyett MR, Dobrzynski H (2011) Molecular architecture of the human specialised atrioventricular conduction axis. J Mol Cell Cardiol 50:642\u2013651","journal-title":"J Mol Cell Cardiol"},{"key":"720_CR87","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R (2005) Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 353:2254\u20132261","journal-title":"N Engl J Med"},{"issue":"3","key":"720_CR1001","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.res.65.3.546","volume":"65","author":"JA Hall","year":"1989","unstructured":"Hall JA, Petch MC, Brown MJ (1989) Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart. Circ Res 65(3):546\u2013553. https:\/\/doi.org\/10.1161\/01.res.65.3.546","journal-title":"Circ Res"},{"issue":"Suppl. S","key":"720_CR88","first-page":"284","volume":"96","author":"SE Harding","year":"1997","unstructured":"Harding SE (1997) Lack of evidence for \u03b23-adrenoceptor modulation of contractile function in human ventricular myocytes [abstract]. Circulation 96(Suppl. S):284","journal-title":"Circulation"},{"key":"720_CR89","doi-asserted-by":"crossref","unstructured":"Harding SD, Armstrong JF, Faccenda E, Southan C, Alexander SPH, Davenport AP, Spedding M, Davies JA (2023) The IUPHAR\/BPS guide to PHARMACOLOGY in 2024. Nucleic Acids Res:gkad944","DOI":"10.1093\/nar\/gkad944"},{"key":"720_CR90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002280050256","volume":"52","author":"U Hauf-Zachariou","year":"1997","unstructured":"Hauf-Zachariou U, Blackwood RA, Gunawardena KA, O'Donnell JG, Garnham S, Pfarr E (1997) Carvedilol versus verapamil in chronic stable angina: a multicentre trial. Eur J Clin Pharmacol 52:95\u2013100","journal-title":"Eur J Clin Pharmacol"},{"key":"720_CR91","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79:e263\u2013e421","journal-title":"J Am Coll Cardiol"},{"key":"720_CR92","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0002-8703(82)90141-7","volume":"104","author":"J Heikkil\u00e4","year":"1982","unstructured":"Heikkil\u00e4 J, Nieminen MS (1982) Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity. Am Heart J 104:464\u2013472","journal-title":"Am Heart J"},{"key":"720_CR93","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00005344-199006000-00014","volume":"15","author":"RE Hershberger","year":"1990","unstructured":"Hershberger RE, Wynn JR, Sundberg L, Bristow MR (1990) Mechanism of action of bucindolol in human ventricular myocardium. J Cardiovasc Pharmacol 15:959\u2013967","journal-title":"J Cardiovasc Pharmacol"},{"key":"720_CR94","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bjp.0704045","volume":"133","author":"JF Heubach","year":"2001","unstructured":"Heubach JF, Graf EM, Molenaar P, J\u00e4ger A, Schr\u00f6der F, Herzig S, Harding SE, Ravens U (2001) Murine ventricular L-type Ca2+ current is enhanced by zinterol via \u03b21-adrenoceptors, and is reduced in TG4 mice overexpressing the human \u03b22-adrenoceptor. Br J Pharmacol 133:73\u201382","journal-title":"Br J Pharmacol"},{"key":"720_CR95","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1124\/mol.65.5.1313","volume":"65","author":"JF Heubach","year":"2004","unstructured":"Heubach JF, Ravens U, Kaumann AJ (2004) Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human \u03b22-adrenoceptors overexpressed in mouse heart. Mol Pharmacol 65:1313\u20131322","journal-title":"Mol Pharmacol"},{"key":"720_CR96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","volume":"369","author":"C Hoffmann","year":"2004","unstructured":"Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz K-N (2004) Comparative pharmacology of human \u03b2-adrenergic receptor subtypes\u2014characterization of stably transfected receptors in CHO cells. Naunyn Schmiedeberg's Arch Pharmacol 369:151\u2013159","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR97","doi-asserted-by":"crossref","first-page":"c4871","DOI":"10.1136\/bmj.c4871","volume":"341","author":"KA Holroyd","year":"2010","unstructured":"Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, Himawan L (2010) Effect of preventive (\u03b2 blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ 341:c4871","journal-title":"BMJ"},{"key":"720_CR98","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0735-1097(97)00527-5","volume":"31","author":"K Hu","year":"1998","unstructured":"Hu K, Gaudron P, Ertl G (1998) Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. J Am Coll Cardiol 31:692\u2013700","journal-title":"J Am Coll Cardiol"},{"issue":"8245","key":"720_CR99","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(81)90881-3","volume":"2","author":"H Ikram","year":"1981","unstructured":"Ikram H, Fitzpatrick D (1981) Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet 2(8245):490\u2013493","journal-title":"Lancet"},{"key":"720_CR100","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/hrt.40.9.998","volume":"40","author":"G Jackson","year":"1978","unstructured":"Jackson G, Harry JD, Robinson C, Kitson D, Jewitt DE (1978) Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol. Br Heart J 40:998\u20131004","journal-title":"Br Heart J"},{"key":"720_CR101","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(77)90890-X","volume":"2","author":"IM James","year":"1977","unstructured":"James IM, Griffith DN, Pearson RM, Newbury P (1977) Effect of oxprenolol on stage-fright in musicians. Lancet 2:952\u2013954","journal-title":"Lancet"},{"key":"720_CR102","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR (2024) 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 149:e1\u2013e156","journal-title":"Circulation"},{"key":"720_CR103","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00210-003-0835-z","volume":"368","author":"SS Joseph","year":"2003","unstructured":"Joseph SS, Lynham JA, Molenaar P, Grace AA, Colledge WH, Kaumann AJ (2003) Intrinsic sympathomimetic activity of (\u2212)-pindolol mediated through a (\u2212)-propranolol-resistant site of the \u03b21-adrenoceptor in human atrium and recombinant receptors. Naunyn Schmiedeberg's Arch Pharmacol 368:496\u2013503","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR104","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH (2018) 2018 European thyroid association guideline for the Management of Graves' hyperthyroidism. Eur Thyroid J 7:167\u2013186","journal-title":"Eur Thyroid J"},{"key":"720_CR105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0165-6147(89)90065-5","volume":"10","author":"AJ Kaumann","year":"1989","unstructured":"Kaumann AJ (1989) Is there a third heart \u03b2-adrenoceptor? Trends Pharmacol Sci 10:316\u2013320","journal-title":"Trends Pharmacol Sci"},{"key":"720_CR106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.1996.tb15159.x","volume":"117","author":"AJ Kaumann","year":"1996","unstructured":"Kaumann AJ (1996) (\u2212)-CGP 12177-induced increase of human atrial contraction through a putative third \u03b2-adrenoceptor. Br J Pharmacol 117:93\u201398","journal-title":"Br J Pharmacol"},{"key":"720_CR107","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/PL00004999","volume":"355","author":"AJ Kaumann","year":"1997","unstructured":"Kaumann AJ, Molenaar P (1997) Modulation of human cardiac function through 4 \u03b2-adrenoceptor populations. Naunyn Schmiedeberg's Arch Pharmacol 355:667\u2013681","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR108","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pharmthera.2008.03.009","volume":"118","author":"AJ Kaumann","year":"2008","unstructured":"Kaumann AJ, Molenaar P (2008) The low-affinity site of the \u03b21-adrenoceptor and its relevance to cardiovascular pharmacology. Pharmacol Ther 118:303\u2013336","journal-title":"Pharmacol Ther"},{"key":"720_CR109","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/BF00173215","volume":"348","author":"AJ Kaumann","year":"1993","unstructured":"Kaumann AJ, Sanders L (1993) Both \u03b21- and \u03b22-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium. Naunyn Schmiedeberg's Arch Pharmacol 348:536\u2013540","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"Supplmenet B","key":"720_CR110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/eurheartj\/10.suppl_B.29","volume":"10","author":"AJ Kaumann","year":"1989","unstructured":"Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ (1989) A comparison of the effects of adrenaline and noradrenaline on human heart: the role of \u03b21- and \u03b22-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10(Supplmenet B):29\u201337","journal-title":"Eur Heart J"},{"key":"720_CR111","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.CIR.99.1.65","volume":"99","author":"A Kaumann","year":"1999","unstructured":"Kaumann A, Bartel S, Molenaar P, Sanders L, Burrell K, Vetter D, Hempel P, Karczewski P, Krause E-G (1999) Activation of \u03b22-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation 99:65\u201372","journal-title":"Circulation"},{"key":"720_CR112","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s002100000336","volume":"363","author":"AJ Kaumann","year":"2001","unstructured":"Kaumann AJ, Engelhardt S, Hein L, Molenaar P, Lohse M (2001) Abolition of (\u2212)-CGP 12177-evoked cardiostimulation in double \u03b21\/\u03b22-adrenoceptor knockout mice. Obligatory role of \u03b21-adrenoceptors for putative \u03b24-adrenoceptor pharmacology. Naunyn Schmiedeberg's Arch Pharmacol 363:87\u201393","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR113","doi-asserted-by":"crossref","first-page":"H182","DOI":"10.1152\/ajpheart.1995.269.1.H182","volume":"38","author":"DM Kaye","year":"1995","unstructured":"Kaye DM, Lefkovits J, Cox H, Lambert G, Jennings G, Turner A, Esler MD (1995) Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. Heart Circ Physiol 38:H182\u2013H188","journal-title":"Heart Circ Physiol"},{"key":"720_CR114","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.RES.87.8.705","volume":"87","author":"JD Kilts","year":"2000","unstructured":"Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott JP, White WD, Davis RD, Newman MF, Reves JG, Schwinn DA, Kwatra MM (2000) \u03b22-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both Gs and Gi. Circ Res 87:705\u2013709","journal-title":"Circ Res"},{"key":"720_CR115","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1073\/pnas.1920310117","volume":"117","author":"J Kim","year":"2020","unstructured":"Kim J, Grotegu CA, Wisler JW, Mao L, Rosenberg PB, Rockman HA, Lefkowitz RJ (2020) The \u03b2-arrestin-biased \u03b2-adrenergic receptor blocker carvedilol enhances skeletal muscle contractility. Proc Natl Acad Sci USA 117:12435\u201312443","journal-title":"Proc Natl Acad Sci USA"},{"key":"720_CR116","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1161\/01.CIR.0000130849.08704.24","volume":"109","author":"M Kindermann","year":"2004","unstructured":"Kindermann M, Maack C, Schaller S, Finkler N, Schmidt K, L\u00e4er S, Wuttke H, Sch\u00e4fers H-J, B\u00f6hm M (2004) Carvedilol but not metoprolol reduces \u03b2-adrenergic responsiveness after complete elimination from plasma in vivo. Circulation 109:3182\u20133190","journal-title":"Circulation"},{"key":"720_CR117","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116:1725\u20131735","journal-title":"Circulation"},{"key":"720_CR118","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.bjp.0702920","volume":"128","author":"AR Kompa","year":"1999","unstructured":"Kompa AR, Summers RJ (1999) Desensitization and resensitization of \u03b21- and putative \u03b24-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure. Br J Pharmacol 128:1399\u20131406","journal-title":"Br J Pharmacol"},{"key":"720_CR119","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/01.RES.79.6.1059","volume":"79","author":"KL Koss","year":"1996","unstructured":"Koss KL, Kranias EG (1996) Phospholamban: a prominent regulator of myocardial contractility. Circ Res 79:1059\u20131063","journal-title":"Circ Res"},{"key":"720_CR120","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1038\/s41467-023-42849-4","volume":"14","author":"E Kostenis","year":"2023","unstructured":"Kostenis E, Gomeza J, Miess-Tanneberg E, Blum NK, Benkel T, Chevign\u00e9 A, Hoffmann C, Kolb P, Nikolaev V, Waldhoer M, Szpakowska M, Inoue A, Schulz S (2023) Reply to: how carvedilol does not activate \u03b22-adrenoceptors. Nat Commun 14:7867","journal-title":"Nat Commun"},{"key":"720_CR121","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9149(97)89342-3","volume":"77","author":"ML Kukin","year":"1996","unstructured":"Kukin ML, Kalman J, Mannino M, Freudenberger R, Buchholz C, Ocampo O (1996) Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure. Am J Cardiol 77:486\u2013491","journal-title":"Am J Cardiol"},{"key":"720_CR122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCEP.114.002065","volume":"8","author":"D Lang","year":"2015","unstructured":"Lang D, Holzem K, Kang C, Xial M, Hwang HJ, Ewald GA, Yamada KA, Efimov IR (2015) Arrhythmogenic remodeling of \u03b22 versus \u03b21 adrenergic signalling in the human failing heart. Circ Arrhythm Electrophysiol 8:409\u2013419","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"720_CR123","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardiores.2004.12.022","volume":"66","author":"J Layland","year":"2005","unstructured":"Layland J, Solaro RJ, Shah AM (2005) Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res 66:12\u201321","journal-title":"Cardiovasc Res"},{"key":"720_CR124","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1172\/JCI114906","volume":"86","author":"MA Lazar","year":"1990","unstructured":"Lazar MA, Chin WW (1990) Nuclear thyroid hormone receptors. J Clin Invest 86:1777\u20131782","journal-title":"J Clin Invest"},{"key":"720_CR125","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.96.7.2197","volume":"96","author":"P LeChat","year":"1997","unstructured":"LeChat P, Escoloano S, Golmard JL, Lardoux H, Witchitz S, Henneman JA, Maisch B, Jaillon P, Boissel J-P, Mallet A, on behalf of the CIBIS Investigators (1997) Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the cardiac insufficiency Bisoprolol Study (CIBIS). Circulation 96:2197\u20132205","journal-title":"Circulation"},{"key":"720_CR126","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1038\/s41467-023-42848-5","volume":"14","author":"RJ Lefkowitz","year":"2023","unstructured":"Lefkowitz RJ, Rockman HA, Shim PJ, Liu S, Ahn S, Pani B, Rajagopal S, Shenoy SK, Bouvier M, Benovic JL, Liggett SB, Ruffolo RR, Bristow MR, Packer M (2023) How carvedilol does not activate \u03b22-adrenoceptors. Nat Commun 14:7866","journal-title":"Nat Commun"},{"key":"720_CR127","doi-asserted-by":"crossref","first-page":"e58334","DOI":"10.1371\/journal.pone.0058334","volume":"8","author":"J Li","year":"2013","unstructured":"Li J, Imtiaz MS, Beard NA, Dulhunty AF, Thorne R, vanHelden DF, Laver DR (2013) \u03b2-adrenergic stimulation increases RyR2 activity via intracellular Ca2+ and Mg2+ regulation. PLoS One 8:e58334","journal-title":"PLoS One"},{"key":"720_CR128","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","volume":"368","author":"P Libby","year":"2013","unstructured":"Libby P (2013) Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 368:2004\u20132013","journal-title":"N Engl J Med"},{"key":"720_CR129","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.2163110","volume":"248","author":"MJ Lohse","year":"1990","unstructured":"Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) \u03b2-Arrestin: a protein that regulates \u03b2-adrenergic receptor function. Science 248:1547\u20131550","journal-title":"Science"},{"key":"720_CR130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1476-5381.1993.tb13902.x","volume":"110","author":"F L\u00f6nnqvist","year":"1993","unstructured":"L\u00f6nnqvist F, Krief S, Strosberg D, Nyberg B, Emorine LJ, Amer P (1993) Evidence for a functional \u03b23-adrenoceptor in man. Br J Pharmacol 110:929\u2013936","journal-title":"Br J Pharmacol"},{"key":"720_CR131","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","volume":"12","author":"C Lydakis","year":"1999","unstructured":"Lydakis C, Lip GY, Beevers M, Beevers DG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12:541\u2013547","journal-title":"Am J Hypertens"},{"key":"720_CR132","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjp.0703400","volume":"130","author":"C Maack","year":"2000","unstructured":"Maack C, Cremers B, Flesch M, H\u00f6per A, S\u00fcdkamp M, B\u00f6hm M (2000) Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium. Br J Pharmacol 130:1131\u20131139","journal-title":"Br J Pharmacol"},{"key":"720_CR133","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff AC, Tsigas E, von Dadelszen P (2022) The 2021 International Society for the Study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 27:148\u2013169","journal-title":"Pregnancy Hypertens"},{"key":"720_CR134","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.63.1.262","volume":"63","author":"IT Mak","year":"1988","unstructured":"Mak IT, Weglicki WB (1988) Protection by \u03b2-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 63:262\u2013266","journal-title":"Circ Res"},{"key":"720_CR135","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1200113","volume":"331","author":"FI Malik","year":"2011","unstructured":"Malik FI, Hartman JJ, Elias KA, Morgan BP, Rodriguez H, Brejc K, Anderson RL, Sueoka SH, Lee KH, Finer JT JT, Sakowicz R, Baliga R, Cox DR, Garard M, Godinez G, Kawas R, Kraynack E, Lenzi D, Lu PP, Muci A, Niu G, Qian X, Pierce DW, Pokrovskii M, Suehiro I, Sylvester S, Tochimoto T, Valdez C, Wang W, Katori T, Kass DA, Shen Y-T, Vatner SF, Morgans DJ (2011) Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science 331:1439\u20131443","journal-title":"Science"},{"key":"720_CR136","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1476-5381.1985.tb08845.x","volume":"85","author":"E Malta","year":"1985","unstructured":"Malta E, Mian MA, Raper C (1985) The in vitro pharmacology of xamoterol (ICI 118,587). Br J Pharmacol 85:179\u2013187","journal-title":"Br J Pharmacol"},{"key":"720_CR137","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1389557053402701","volume":"5","author":"R Mannhold","year":"2005","unstructured":"Mannhold R (2005) The impact of lipophilicity in drug research: a case report on \u03b2-blockers. Mini Rev Med Chem 5:197\u2013205","journal-title":"Mini Rev Med Chem"},{"key":"720_CR138","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4254\/wjh.v2.i6.208","volume":"27","author":"M Martell","year":"2010","unstructured":"Martell M, Coll M, Ezkurdia N, Raurell I, Genesc\u00e0 J (2010) Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 27:208\u2013220","journal-title":"World J Hepatol"},{"key":"720_CR139","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","volume":"101","author":"SO Marx","year":"2000","unstructured":"Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR (2000) PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101:365\u2013376","journal-title":"Cell"},{"key":"720_CR140","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1074\/jbc.274.18.12670","volume":"274","author":"DA Mason","year":"1999","unstructured":"Mason DA, Moore JD, Green SA, Liggett SB (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human \u03b21-adrenergic receptor. J Biol Chem 274:12670\u201312674","journal-title":"J Biol Chem"},{"key":"720_CR141","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.117.311589","volume":"122","author":"J Mayourian","year":"2018","unstructured":"Mayourian J, Ceholski DK, Gonzalez DM, Cashman TJ, Sahoo S, Hajjar RJ, Costa KD (2018) Physiologic, pathologic, and therapeutic paracrine modulation of cardiac excitation-contraction coupling. Circ Res 122:167\u2013183","journal-title":"Circ Res"},{"key":"720_CR142","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK (2023) ESC Scientific Document Group. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 44:3627\u20133639","journal-title":"Eur Heart J"},{"key":"720_CR143","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","volume":"45","author":"J McMurray","year":"2005","unstructured":"McMurray J, K\u00f8ber L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J, Remme W, Sharpe N, Ford I (2005) Antiarrhythmic effect of carvedilol after acute myocardial infarction. J Am Cardiol Soc 45:525\u2013530","journal-title":"J Am Cardiol Soc"},{"key":"720_CR144","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1073\/pnas.1821660116","volume":"116","author":"JW McNamara","year":"2019","unstructured":"McNamara JW, Singh RR, Sadayappan S (2019) Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin. Proc Natl Acad Sci USA 116:11731\u201311736","journal-title":"Proc Natl Acad Sci USA"},{"key":"720_CR145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1476-5381.1984.tb16488.x","volume":"82","author":"GA McPherson","year":"1984","unstructured":"McPherson GA, Malta E, Molenaar P, Raper C (1984) The affinity and efficacy of the selective \u03b21-adrenoceptor stimulant RO363 at \u03b21- and \u03b22-adrenoceptor sites. Br J Pharmacol 82:897\u2013904","journal-title":"Br J Pharmacol"},{"key":"720_CR146","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM199108293250905","volume":"325","author":"IT Meredith","year":"1991","unstructured":"Meredith IT, Broughton A, Jennings GL, Esler MD (1991) Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325:618\u2013624","journal-title":"N Engl J Med"},{"key":"720_CR147","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group (1999) Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"720_CR148","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nm930","volume":"9","author":"J Mialet Perez","year":"2003","unstructured":"Mialet Perez J, Rathz DA, Petrashevskaya NN, Hanh H, Wagoner LE, Schwartz A, Dorn GW II, Liggett SB (2003) \u03b21-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9:1300\u20131305","journal-title":"Nat Med"},{"key":"720_CR149","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3390\/cells9122584","volume":"9","author":"LYM Michel","year":"2020","unstructured":"Michel LYM, Farah C, Balligand JL (2020) The Beta3 adrenergic receptor in healthy and pathological cardiovascular tissues. Cells 9:2584","journal-title":"Cells"},{"key":"720_CR150","doi-asserted-by":"crossref","first-page":"C999","DOI":"10.1152\/ajpcell.00267.2014","volume":"307","author":"E Minobe","year":"2014","unstructured":"Minobe E, Maeda S, Xu J, Hao L, Kameyama A, Kameyama M (2014) A new phosphorylation site in cardiac L-type Ca2+ channels (Cav1.2) responsible for its cAMP-mediated modulation. Am J Physiol Cell Physiol 307:C999\u2013C1009","journal-title":"Am J Physiol Cell Physiol"},{"key":"720_CR151","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1111\/bph.13897","volume":"174","author":"W Mo","year":"2017","unstructured":"Mo W, Michel MC, Lee XW, Kaumann AJ, Molenaar P (2017) The \u03b23-adrenoceptor agonist mirabegron increases human atrial force through \u03b21-adrenoceptors: an indirect mechanism? Br J Pharmacol 174:2706\u20132715","journal-title":"Br J Pharmacol"},{"key":"720_CR152","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jacc.2007.01.064","volume":"49","author":"M Mochizuki","year":"2007","unstructured":"Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M (2007) Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 49:1722\u20131732","journal-title":"J Am Coll Cardiol"},{"key":"720_CR153","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tips.2005.05.005","volume":"26","author":"P Molenaar","year":"2005","unstructured":"Molenaar P, Parsonage WA (2005) Fundamental considerations of \u03b2-adrenoceptor subtypes in human heart failure. Trends Pharmacol Sci 26:368\u2013375","journal-title":"Trends Pharmacol Sci"},{"key":"720_CR154","first-page":"1041","volume":"241","author":"P Molenaar","year":"1987","unstructured":"Molenaar P, Summers RJ (1987) Characterization of Beta-1 and Beta-2 adrenoceptors in Guinea pig atrium: functional and receptor binding studies. J Pharmacol Exp Ther 241:1041\u20131047","journal-title":"J Pharmacol Exp Ther"},{"key":"720_CR155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00634244","volume":"331","author":"P Molenaar","year":"1985","unstructured":"Molenaar P, McPherson GA, Malta E, Raper C (1985) The influence of molecular structure on the affinity and efficacy of some \u03b2-adrenoceptor agonists. Naunyn Schmiedeberg's Arch Pharmacol 331:240\u2013246","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR156","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1440-1681.1997.tb02107.x","volume":"24","author":"P Molenaar","year":"1997","unstructured":"Molenaar P, Sarsero D, Kaumann AJ (1997) Proposal for the interaction of non-conventional partial agonists and catecholamines with the \u2018putative \u03b24-adrenoceptor\u2019 in mammalian heart. Clin Exp Pharmacol Physiol 24:647\u2013656","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"720_CR157","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/01.CIR.102.15.1814","volume":"102","author":"P Molenaar","year":"2000","unstructured":"Molenaar P, Bartel S, Cochrane A, Vetter D, Jalali H, Pohlner P, Burrell K, Karczewski P, Krause E-G, Kaumann A (2000) Both \u03b22- and \u03b21-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of \u03b22-adrenergic receptors to Gs-protein. Circulation 102:1814\u20131821","journal-title":"Circulation"},{"key":"720_CR158","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cardiores.2005.08.024","volume":"69","author":"P Molenaar","year":"2006","unstructured":"Molenaar P, Christ T, Ravens U, Kaumann A (2006) Carvedilol blocks \u03b22- more than \u03b21-adrenoceptors in human heart. Cardiovasc Res 69:128\u2013139","journal-title":"Cardiovasc Res"},{"key":"720_CR159","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1440-1681.2007.04730.x","volume":"34","author":"P Molenaar","year":"2007","unstructured":"Molenaar P, Chen L, Semmler ABT, Parsonage WA, Kaumann AJ (2007a) Human heart \u03b2-adrenoceptors: \u03b21-adrenoceptor diversification through \u2018affinity states\u2019 and polymorphism. Clin Exp Pharmacol Physiol 34:1020\u20131028","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"720_CR160","doi-asserted-by":"crossref","unstructured":"Molenaar P, Savarimuthu SM, Sarsero D, Chen L, Semmler ABT, Carle A, Yang I, Bartel S, Vetter D, Beyerd\u00f6rfer I, Georg Krause E-G, Kaumann AJ (2007b) (\u2212)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through \u03b22-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling. Naunyn Schmiedeberg's Arch Pharmacol 375:11\u201328","DOI":"10.1007\/s00210-007-0138-x"},{"key":"720_CR161","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bph.12167","volume":"169","author":"P Molenaar","year":"2013","unstructured":"Molenaar P, Christ T, Hussain RI, Engel A, Berk E, Gillette KT, Chen L, Galindo-Tovar A, Krobert KA, Ravens U, Levy FO, Kaumann AJ (2013) PDE3, but not PDE4, reduces \u03b21- and \u03b22-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. Br J Pharmacol 169:528\u2013538","journal-title":"Br J Pharmacol"},{"key":"720_CR162","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00210-014-0974-4","volume":"387","author":"P Molenaar","year":"2014","unstructured":"Molenaar P, Christ T, Berk E, Engel A, Gillette KT, Galindo-Tovar A, Ravens U, Kaumann AJ (2014) Carvedilol induces greater control of \u03b22- than \u03b21-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium. Naunyn Schmiedeberg's Arch Pharmacol 387:629\u2013640","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR163","unstructured":"Molenaar P, Mo, W, Cheesman E, Dashwood AM, Kaumann AJ, Beard NA (2019) Both \u03b21- and \u03b22-adrenoceptors mediate arrhythmic contractions, ryanodine receptor opening and phosphorylation in human failing hearts: control by PDE3. Australasian Society of Clinical and Experimental Pharmacologists Scientific Meeting, Queenstown, Abstract 101"},{"key":"720_CR164","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1527-3466.2002.tb00079.x","volume":"20","author":"S Moniotte","year":"2002","unstructured":"Moniotte S, Balligand J-L (2002) Potential use of \u03b23-adrenoceptor antagonists in heart failure therapy. Cardiovasc Drug Rev 20:19\u201326","journal-title":"Cardiovasc Drug Rev"},{"key":"720_CR165","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.CIR.103.12.1649","volume":"103","author":"S Moniotte","year":"2001","unstructured":"Moniotte S, Kobzik L, Feron O, Trochu J-N, Gauthier C, Balligand J-L (2001) Upregulation of \u03b23-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103:1649\u20131655","journal-title":"Circulation"},{"issue":"6","key":"720_CR1002","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/0735-1097(88)90287-2","volume":"11","author":"F Morady","year":"1988","unstructured":"Morady F, Nelson SD, Kou WH, Pratley R, Schmaltz S, De Buitleir M, Halter JB (1988) Electrophysiologic effects of epinephrine in humans. J Am Coll Cardiol 11(6):1235\u20131244. https:\/\/doi.org\/10.1016\/0735-1097(88)90287-2","journal-title":"J Am Coll Cardiol"},{"key":"720_CR166","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s001099900031","volume":"77","author":"I Morano","year":"1999","unstructured":"Morano I (1999) Tuning the human heart molecular motors by myosin light chains. J Mol Med 77:544\u2013555","journal-title":"J Mol Med"},{"key":"720_CR167","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jcin.2016.05.048","volume":"9","author":"AA Motivala","year":"2016","unstructured":"Motivala AA, Parikh V, Roe M, Dai D, Abbott JD, Prasad A, Mukherjee D (2016) Predictors, trends, and outcomes (among older patients \u226565 years of age) associated with beta-blocker use in patients with stable angina undergoing elective percutaneous coronary intervention: insights from the NCDR registry. JACC Cardiovasc Interv 9:1639\u20131648","journal-title":"JACC Cardiovasc Interv"},{"key":"720_CR1003","doi-asserted-by":"publisher","unstructured":"Motomura S, Hashimoto K (1992) Beta 2-adrenoceptor-mediated positive dromotropic effects on atrioventricular node of dogs. Am J Phys Jan;262(1 Pt 2):H123-H129. https:\/\/doi.org\/10.1152\/ajpheart.1992.262.1.H123.","DOI":"10.1152\/ajpheart.1992.262.1.H123"},{"key":"720_CR168","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","volume":"116","author":"D Mozaffarian","year":"2007","unstructured":"Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JGF, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC (2007) Prediction of mode of death in heart failure. The Seattle heart failure model. Circulation 116:392\u2013398","journal-title":"Circulation"},{"key":"720_CR169","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40256-015-0129-0","volume":"15","author":"BN Mukete","year":"2015","unstructured":"Mukete BN, Cassidy M, Ferdinand KC, Le Jemtel TH (2015) Long-term anti-hypertensive therapy and stroke prevention: a meta-analysis. Am J Cardiovasc Drugs 15:243\u2013257","journal-title":"Am J Cardiovasc Drugs"},{"key":"720_CR170","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"SS Naidu","year":"2022","unstructured":"Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, Grines CL, Diercks DB, Hall S, Kapur NK, Kent W, Rao SV, Samsky MD, Thiele H, Truesdell AG, Henry TD (2022) SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol 79:933\u2013946","journal-title":"J Am Coll Cardiol"},{"key":"720_CR171","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S2213-8587(23)00256-5","volume":"11","author":"MA Nazari","year":"2023","unstructured":"Nazari MA, Hasan R, Haigney M, Maghsoudi A, Lenders JWM, Carey RM, Pacak K (2023) Catecholamine-induced hypertensive crises: current insights and management. Lancet Diabetes Endocrinol 11:942\u2013954","journal-title":"Lancet Diabetes Endocrinol"},{"key":"720_CR172","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00006842-198211000-00008","volume":"44","author":"KA Neftel","year":"1982","unstructured":"Neftel KA, Adler RH, K\u00e4ppeli L, Rossi M, Dolder M, K\u00e4ser HE, Bruggesser HH, Vorkauf H (1982) Stage fright in musicians: a model illustrating the effect of beta blockers. Psychosom Med 44:461\u2013469","journal-title":"Psychosom Med"},{"key":"720_CR173","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.hlc.2018.06.1042","volume":"27","author":"JJ Atherton","year":"2018","unstructured":"NHFA CSANZ Heart Failure Guidelines Working Group, Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, Hopper I, Kistler PM, Briffa T, Wong J, Abhayaratna W, Thomas L, Audehm R, Newton P, O'Loughlin J, Branagan M, Connell C (2018) National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and Management of Heart Failure in Australia 2018. Heart Lung Circ 27:1123\u20131208","journal-title":"Heart Lung Circ"},{"key":"720_CR174","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1185988","volume":"237","author":"VO Nikolaev","year":"2010","unstructured":"Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE, Gorelik J (2010) \u03b22-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 237:1653\u20131657","journal-title":"Science"},{"key":"720_CR175","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40262-014-0189-3","volume":"53","author":"R Ogawa","year":"2014","unstructured":"Ogawa R, Stachnik JM, Echizen H (2014) Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally). Clin Pharmacokinet 53:1083\u20131114","journal-title":"Clin Pharmacokinet"},{"key":"720_CR176","first-page":"970","volume":"25","author":"HG Oldham","year":"1997","unstructured":"Oldham HG, Clarke SE (1997) In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(\u2212)-carvedilol. Drug Metab Dispos 25:970\u2013977","journal-title":"Drug Metab Dispos"},{"key":"720_CR177","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.CIR.72.4.681","volume":"72","author":"M Packer","year":"1985","unstructured":"Packer M (1985) Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 72:681\u2013685","journal-title":"Circulation"},{"key":"720_CR178","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilvert EM, Shusterman HH, for the U.S. Carvedilol Heart Failure Study Group (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349\u20131355","journal-title":"N Engl J Med"},{"key":"720_CR179","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, AJS C, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, De Mets DL, for the Carvedilol Prospective Randomized Cumulative Survival Study Group (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651\u20131658","journal-title":"N Engl J Med"},{"key":"720_CR180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","volume":"145","author":"PJ Peltenburg","year":"2022","unstructured":"Peltenburg PJ, Kallas D, Bos JM, Lieve KVV, Franciosi S, Roston TM, Denjoy I, Sorensen KB, Ohno S, Roses-Noguer F, Aiba T, Maltret A, LaPage MJ, Atallah J, Giudicessi JR, Clur SB, Blom NA, Tanck M, Extramiana F, Kato K, Barc J, Borggrefe M, Behr ER, Sarquella-Brugada G, Tfelt-Hansen J, Zorio E, Swan H, Kammeraad JAE, Krahn AD, Davis A, Sacher F, Schwartz PJ, Roberts JD, Skinner JR, van den Berg MP, Kannankeril PJ, Drago F, Robyns T, Haugaa K, Tavacova T, Semsarian C, Till J, Probst V, Brugada R, Shimizu W, Horie M, Leenhardt A, Ackerman MJ, Sanatani S, van der Werf C, Wilde AAM (2022) An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia. Circulation 145:333\u2013344","journal-title":"Circulation"},{"key":"720_CR181","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0008-6363(98)00002-9","volume":"38","author":"B Pelzmann","year":"1998","unstructured":"Pelzmann B, Schaffer P, Bernhart E, Lang P, M\u00e4chler H, Rigler B, Koidl B (1998) L-type calcium current in human ventricular myocytes at a physiological temperature from children with tetralogy of Fallot. Cardiovasc Res 38:424\u2013432","journal-title":"Cardiovasc Res"},{"key":"720_CR182","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0008-6363(02)00841-6","volume":"57","author":"B Pieske","year":"2003","unstructured":"Pieske B, Houser SR (2003) [Na+]i handling in the failing human heart. Cardiovasc Res 57:874\u2013886","journal-title":"Cardiovasc Res"},{"key":"720_CR183","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tcm.2003.12.002","volume":"14","author":"SM Pogwizd","year":"2004","unstructured":"Pogwizd SM, Bers DM (2004) Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 14:61\u201366","journal-title":"Trends Cardiovasc Med"},{"key":"720_CR184","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/hh1101.091193","volume":"88","author":"SM Pogwizd","year":"2001","unstructured":"Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM (2001) Arrhythmogenesis and contractile dysfunction in heart failure. Roles of sodium-calcium exchange, inward rectifier potassium current, and residual \u03b2-adrenergic responsiveness. Circ Res 88:1159\u20131167","journal-title":"Circ Res"},{"key":"720_CR185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","volume":"362","author":"PA Poole-Wilson","year":"2003","unstructured":"Poole-Wilson PA, Swedberg K, Cleland JGF, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A, for the COMET Investigators (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET): randomised controlled trial. Lancet 362:7\u201313","journal-title":"Lancet"},{"issue":"4","key":"720_CR186","doi-asserted-by":"crossref","first-page":"e00602","DOI":"10.1002\/prp2.602","volume":"8","author":"RGW Proudman","year":"2020","unstructured":"Proudman RGW, Pupo AS, Baker JG (2020) The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants, and antipsychotics for the human \u03b11A, \u03b11B, and \u03b11D-adrenoceptors. Pharmacol Res Perspect 8(4):e00602","journal-title":"Pharmacol Res Perspect"},{"key":"720_CR187","first-page":"300936","volume":"10","author":"RGW Proudman","year":"2022","unstructured":"Proudman RGW, Akinaga J, Baker JG (2022) The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants and antipsychotics for the human \u03b12A, \u03b12B and \u03b12C-adrenoceptors and comparison with human \u03b11 and \u03b2-adrenoceptors. Pharmacol Res Perspect 10:300936","journal-title":"Pharmacol Res Perspect"},{"key":"720_CR188","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000068316.53218.49","volume":"107","author":"S Reiken","year":"2003","unstructured":"Reiken S, Wehrens XHT, Vest JA, Barbone A, Klotz S, Mancini D, Burkhoff D, Marks AR (2003) \u03b2-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107:2459\u20132466","journal-title":"Circulation"},{"key":"720_CR189","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343\u20131421","journal-title":"Thyroid"},{"key":"720_CR190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/19336950.2020.1740502","volume":"14","author":"D Roybal","year":"2020","unstructured":"Roybal D, Hennessey JA, Marx SO (2020) The quest to identify the mechanism underlying adrenergic regulation of cardiac Ca2+ channels. Channels 14:123\u2013131","journal-title":"Channels"},{"key":"720_CR191","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198303173081102","volume":"308","author":"L Ryd\u00e9n","year":"1983","unstructured":"Ryd\u00e9n L, Ariniego R, Arnman K, Herlitz J, Hjalmarson A, Holmberg S, Reyes C, Smedg\u00e5rd P, Svedberg K, Vedin A, Waagstein F, Waldenstr\u00f6m A, Wilhelmsson C, Wedel H, Yamamoto M (1983) A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 308:614\u2013618","journal-title":"N Engl J Med"},{"key":"720_CR192","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.bjp.0702045","volume":"125","author":"D Sarsero","year":"1998","unstructured":"Sarsero D, Fujiwara T, Molenaar P, Angus JA (1998) Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. Br J Pharmacol 125:109\u2013119","journal-title":"Br J Pharmacol"},{"key":"720_CR193","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00210-002-0652-9","volume":"367","author":"D Sarsero","year":"2003","unstructured":"Sarsero D, Russell FD, Lynham JA, Rabnott G, Yang I, Fong KM, Li L, Kaumann AJ, Molenaar P (2003) (\u2212)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the \u03b21-adrenoceptor. Naunyn Schmiedeberg's Arch Pharmacol 367:10\u201321","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR194","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0735-1097(95)00489-0","volume":"27","author":"S Savonitto","year":"1996","unstructured":"Savonitto S, Ardissiono D, Egstrup K, Rasmussen K, Bae EA, Omland T, Schjelderup-Mathiesen PM, Marraccini P, Wahlqvist I, Merlini PA, Rehnqvist N (1996) Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the international multicenter angina exercise (IMAGE) study. J Am Coll Cardiol 27:311\u2013316","journal-title":"J Am Coll Cardiol"},{"key":"720_CR195","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.RES.87.9.774","volume":"87","author":"K Schlotthauer","year":"2000","unstructured":"Schlotthauer K, Bers DM (2000) Sarcoplasmic reticulum Ca2+ release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials. Circ Res 87:774\u2013780","journal-title":"Circ Res"},{"key":"720_CR196","first-page":"1084","volume":"285","author":"MV Sennitt","year":"1998","unstructured":"Sennitt MV, Kaumann AJ, Molenaar P, Beeley LJ, Young PW, Kelly J, Chapman H, Henson SM, Berge JM, Dean DK, Kotecha NR, Morgan HKA, Rami HK, Ward RW, Thompson M, Wilson S, Smith SA, Cawthorne MA, Stock ML, Arch JRS (1998) The contribution of classical (\u03b21\/2-) and atypical \u03b2- adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel \u03b23-adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther 285:1084\u20131095","journal-title":"J Pharmacol Exp Ther"},{"key":"720_CR197","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/HJH.0000000000001856","volume":"37","author":"G Seravalle","year":"2019","unstructured":"Seravalle G, Quarti-Trevano F, Dell\u2019Oro R, Gronda E, Spaziani D, Facchetti R, Cuspidi C, Mancia G, Grassi G (2019) Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. J Hypertens 37:443\u2013448","journal-title":"J Hypertens"},{"key":"720_CR198","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jceh.2012.08.001","volume":"2","author":"M Sharma","year":"2012","unstructured":"Sharma M, Rameshbabu CS (2012) Collateral pathways in portal hypertension. J Clin Exp Hepatol 2:338\u2013352","journal-title":"J Clin Exp Hepatol"},{"key":"720_CR199","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/thy.2007.0252","volume":"18","author":"JE Silva","year":"2008","unstructured":"Silva JE, Bianco SD (2008) Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid 18:157\u2013165","journal-title":"Thyroid"},{"key":"720_CR200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/01.RES.83.5.471","volume":"83","author":"RJ Solaro","year":"1998","unstructured":"Solaro RJ, Rarick HM (1998) Troponin and Tropomyosin. Proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 83:471\u2013480","journal-title":"Circ Res"},{"key":"720_CR201","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","volume":"15","author":"T Sprenger","year":"2018","unstructured":"Sprenger T, Viana M, Tassorelli C (2018) Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics 15:313\u2013323","journal-title":"Neurotherapeutics"},{"key":"720_CR202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0269881115612236","volume":"30","author":"SA Steenen","year":"2016","unstructured":"Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A (2016) Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. J Psychopharmacol 30:128\u2013139","journal-title":"J Psychopharmacol"},{"key":"720_CR203","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM200105313442202","volume":"344","author":"The Beta-Blocker Evaluation of Survival Trial Investigators","year":"2001","unstructured":"The Beta-Blocker Evaluation of Survival Trial Investigators (2001) A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344:1659\u20131667","journal-title":"N Engl J Med"},{"key":"720_CR204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(90)91517-E","volume":"336","author":"The Xamoterol in Severe Heart Failure Study Group","year":"1990","unstructured":"The Xamoterol in Severe Heart Failure Study Group (1990) Xamoterol in severe heart failure. Lancet 336:1\u20136","journal-title":"Lancet"},{"key":"720_CR205","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Executive Group on behalf of the Joint European Society of Cardiology (ESC), American College of Cardiology (ACC), American Heart Association (AHA), World Heart Federation (WHF), Task Force for the Universal Definition of Myocardial Infarction (2018) Fourth universal definition of myocardial infarction. J Am Coll Cardiol 72:2231\u20132264","journal-title":"J Am Coll Cardiol"},{"key":"720_CR206","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0002-9343(89)80614-X","volume":"87","author":"PT Trzepacz","year":"1989","unstructured":"Trzepacz PT, Klein I, Roberts M, Greenhouse J, Levey GS (1989) Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med 87:558\u2013561","journal-title":"Am J Med"},{"key":"720_CR207","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.CIR.87.2.454","volume":"87","author":"M Ungerer","year":"1993","unstructured":"Ungerer M, B\u00f6hm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of \u03b2-adrenergic receptor kinase and \u03b21-adrenergic receptors in the failing human heart. Circulation 87:454\u2013463","journal-title":"Circulation"},{"key":"720_CR208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.RES.74.2.206","volume":"74","author":"M Ungerer","year":"1994","unstructured":"Ungerer M, Parruti G, Bohm M, Puzicha M, DeBlasi A, Erdmann E, Lohse MJ (1994) Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 74:206\u2013213","journal-title":"Circ Res"},{"key":"720_CR209","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/hrt.37.10.1022","volume":"37","author":"F Waagstein","year":"1975","unstructured":"Waagstein F, Hjalmarson \u00c5, Varnauskas E, Wallentin I (1975) Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37:1022\u20131036","journal-title":"Br Heart J"},{"key":"720_CR210","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","volume":"342","author":"F Waagstein","year":"1993","unstructured":"Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A, for the Metoprolol in Dilated Cardiomyopathy (MDC), Trial Study Group (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441\u20131446","journal-title":"Lancet"},{"key":"720_CR211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00500912","volume":"327","author":"M Walter","year":"1984","unstructured":"Walter M, Lemoine H, Kaumann AJ (1984) Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of Guinea pig. Role of \u03b2-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn Schmiedeberg's Arch Pharmacol 327:159\u2013175","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"720_CR212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2017.01.016","volume":"140","author":"K Walweel","year":"2017","unstructured":"Walweel K, Molenaar P, Imtiaz MS, Denniss A, dos Remedios C, van Helden DF, Dulhunty AF, Laver DR, Beard NA (2017) Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts. J Mol Cell Cardiol 140:53\u201362","journal-title":"J Mol Cell Cardiol"},{"key":"720_CR213","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yjmcc.2019.03.018","volume":"130","author":"K Walweel","year":"2019","unstructured":"Walweel K, Gomez-Hurtado N, Rebbeck RT, Oo YW, Beard NA, Molenaar P, dos Remedios C, van Helden DF, Cornea RL, Knollmann BC, Laver DR (2019) Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814. J Mol Cell Cardiol 130:96\u2013106","journal-title":"J Mol Cell Cardiol"},{"key":"720_CR214","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41467-017-01855-z","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Hanada K, Staus DP, Makara MA, Dahal GR, Chen Q, Ahles A, Engelhardt S, Rockman HA (2017) G\u03b1i is required for carvedilol-induced \u03b21 adrenergic receptor \u03b2-arrestin biased signalling. Nat Commun 8:1706","journal-title":"Nat Commun"},{"key":"720_CR215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9149(76)90293-9","volume":"37","author":"SG Warren","year":"1976","unstructured":"Warren SG, Brewer DL, Orgain ES (1976) Long-term propranolol therapy for angina pectoris. Am J Cardiol 37:420\u2013426","journal-title":"Am J Cardiol"},{"key":"720_CR216","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9149(98)00507-4","volume":"82","author":"R Weiss","year":"1998","unstructured":"Weiss R, Ferry D, Pickering E, Smith LK, Dennish G 3rd, Krug-Gourley S, Lukas MA (1998) Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group. Am J Cardiol 82:927\u2013931","journal-title":"Am J Cardiol"},{"key":"720_CR217","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.113.301781","volume":"113","author":"S Weiss","year":"2013","unstructured":"Weiss S, Oz S, Benmocha A, Dascal N (2013) Regulation of cardiac L-type Ca2+ channel Cav1.2 via the \u03b2-adrenergic-cAMP-protein kinase a pathway. Old dogmas, advances, and new uncertainties. Circ Res 113:617\u2013631","journal-title":"Circ Res"},{"key":"720_CR218","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/S0021-9258(17)40528-X","volume":"25","author":"LT Williams","year":"1977","unstructured":"Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR Jr (1977) Thyroid hormone regulation of \u03b2-adrenergic receptor number. J Biol Chem 25:2787\u20132279","journal-title":"J Biol Chem"},{"key":"720_CR219","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","volume":"104","author":"JW Wisler","year":"2007","unstructured":"Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, Shenoy SK, Lefkowitz RJ (2007) A unique mechanism of \u03b2-blocker action: Carvedilol stimulates \u03b2-arrestin signalling. PNAS 104:16657\u201316662","journal-title":"PNAS"},{"key":"720_CR220","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1111\/bph.12965","volume":"172","author":"AY-H Woo","year":"2015","unstructured":"Woo AY-H, Song Y, Xiao R-P, Zhu W (2015) Biased \u03b22-adrenoceptor signalling in heart failure: pathophysiology and drug discovery. Br J Pharmacol 172:5444\u20135456","journal-title":"Br J Pharmacol"},{"key":"720_CR221","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41467-018-06193-2","volume":"9","author":"MS Woody","year":"2018","unstructured":"Woody MS, Greenberg MJ, Barua B, Winkelmann DA, Goldman YE, Ostap EM (2018) Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working stroke. Nat Commun 9:3838","journal-title":"Nat Commun"},{"key":"720_CR222","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1016\/S0021-9258(17)32287-1","volume":"269","author":"RP Xiao","year":"1994","unstructured":"Xiao RP, Hohl C, Altschuld R, Jones L, Livingston B, Ziman B, Tantini B, Lakatta EG (1994) \u03b22-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem 269:19151\u201319156","journal-title":"J Biol Chem"},{"key":"720_CR223","first-page":"322","volume":"47","author":"R-P Xiao","year":"1995","unstructured":"Xiao R-P, Ji X, Lakatta EG (1995) Functional coupling of the \u03b22-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 47:322\u2013329","journal-title":"Mol Pharmacol"},{"key":"720_CR224","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.RES.84.1.43","volume":"84","author":"R-P Xiao","year":"1999","unstructured":"Xiao R-P, Avdonin P, Zhou Y-Y, Cheng H, Akhter SA, Eschenhagen T, Lefkowitz RJ, Koch WJ, Lakatta EG (1999) Coupling of \u03b22-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myoctyes. Circulation 84:43\u201352","journal-title":"Circulation"},{"key":"720_CR225","first-page":"92","volume":"263","author":"T-L Yue","year":"1992","unstructured":"Yue T-L, Cheng H-Y, Lysko PG, McKenna PJ, Feuerstein R, Gu J-L, Lysko KA, Davis LL, Feuerstein G (1992) Carvedilol, a new vasodilator and Beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 263:92\u201398","journal-title":"J Pharmacol Exp Ther"},{"key":"720_CR226","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm.2406","volume":"17","author":"Q Zhou","year":"2011","unstructured":"Zhou Q, Xiao J, Jiang D, Wang R, Vembaiyan K, Wang A, Smith CD, Xie C, Chen W, Zhang J, Tian X, Jones PP, Zhong X, Guo A, Chen H, Zhang L, Zhu W, Yang D, Li X, Chen J, Gillis AM, Henry J, Duff HJ, Cheng H, Feldman AM, Song L-S, Fill M, Thomas G, Back TG, Chen SRW (2011) Carvedilol and its new analogs suppress arrhythmogenic store overload\u2013induced Ca2+ release. Nat Med 17:1003\u20131009","journal-title":"Nat Med"},{"key":"720_CR227","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.98.4.1607","volume":"98","author":"W-Z Zhu","year":"2001","unstructured":"Zhu W-Z, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao R-P (2001) Dual modulation of cell survival and cell death by \u03b22-adrenergic signalling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A 98:1607\u20131612","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2024_720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:03:40Z","timestamp":1717700620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2024_720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":230,"URL":"https:\/\/doi.org\/10.1007\/164_2024_720","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"7 June 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}